Related Experiment Video

Updated: Apr 11, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.9K

Inhibition of Monoamine Oxidase by Anithiactins from Streptomyces sp

Hyun Woo Lee1, Won Kyeong Jung2, Hee Jung Kim1

  • 1Department of Pharmacy, Sunchon National University, Suncheon 540-950, Republic of Korea.

Journal of Microbiology and Biotechnology
|June 3, 2015
PubMed

Insights

Anithiactin A selectively inhibits monoamine oxidase-A (MAO-A), a key enzyme in neurotransmitter metabolism. This compound shows potential as a novel therapeutic lead for MAO-A related conditions.

Area of Science:

  • Biochemistry
  • Enzymology
  • Pharmacology

Background:

  • Monoamine oxidase (MAO) enzymes are crucial for neurotransmitter catabolism.
  • MAO exists in two isoforms, MAO-A and MAO-B, with distinct substrate specificities and tissue distributions.
  • Dysregulation of MAO activity is implicated in various neurological and psychiatric disorders.

Purpose of the Study:

  • To investigate the inhibitory potential of anithiactins A-C, isolated from Streptomyces sp., against MAO-A and MAO-B.
  • To characterize the inhibitory mechanism and potency of active anithiactin compounds.

Main Methods:

  • In vitro enzymatic assays were performed to assess the inhibitory activity of anithiactins A-C against purified MAO-A and MAO-B.
  • Enzyme kinetics studies were conducted to determine the mode of inhibition (competitive, non-competitive, etc.) and inhibition constants (IC50, Ki).

Main Results:

  • Anithiactin A demonstrated selective and moderate inhibitory activity against MAO-A (IC50 = 13.0 µM), with minimal effect on MAO-B.
  • Anithiactins B and C exhibited weaker inhibitory effects on both MAO isoforms.
  • Anithiactin A was identified as a reversible and competitive inhibitor of MAO-A, with a Ki value of 1.84 µM.

Conclusions:

  • Anithiactin A is a selective, reversible, and moderately potent inhibitor of MAO-A.
  • The hydrophobic methyl group in anithiactin A appears critical for its MAO-A inhibitory activity.
  • Anithiactin A represents a promising lead compound for the development of novel therapeutic agents targeting MAO-A.
Keywords:
Anithiactin AStreptomyces sp.competitive inhibitormonoamine oxidaseselective inhibitor

More Related Videos

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.5K
Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.09:21

Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.

Published on: February 15, 2019

11.3K

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
66
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
81
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.9K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K